We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+23.66%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.11B
AUM Growth
+$195M
(+21%)
Cap. Flow
+$57.8M
Cap. Flow
% of AUM
5.19%
Top 10 Holdings %
Top 10 Hldgs %
48.19%
Holding
72
New
18
Increased
12
Reduced
16
Closed
18
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
+$49.7M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$46.9M |
| 3 |
ALR
Alere Inc
ALR
|
+$29.1M |
| 4 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$27.8M |
| 5 |
Biogen
BIIB
|
+$21.5M |
Top Sells
| 1 |
RAD
Rite Aid Corporation
RAD
|
+$45.4M |
| 2 |
CELG
Celgene Corp
CELG
|
+$38.3M |
| 3 |
Gilead Sciences
GILD
|
+$34.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$19.4M |
| 5 |
AstraZeneca
AZN
|
+$18.2M |
Sector Composition
| 1 | Healthcare | 81.12% |
| 2 | Financials | 2.03% |
| 3 | Technology | 1.63% |
| 4 | Communication Services | 1.57% |
| 5 | Consumer Staples | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $96.7M | 8.69% |
13,125,594
+1,267,300
| +11% | +$9.02M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $66.9M | 6% |
900,879
+179,247
| +25% | +$12.7M |
|
|
FOLD
3
DELISTED
Amicus Therapeutics
FOLD
| $63.5M | 5.7% |
5,832,228
-1,043,046
| -15% | -$9.19M |
|
4
Bausch Health
BHC
$1.83B
| $53.3M | 4.79% |
268,519
-69,958
| -21% | -$12.4M |
|
|
5
Teva Pharmaceuticals
TEVA
$36.7B
| $53.2M | 4.78% |
+853,973
| New | +$49.7M |
|
|
ENDP
6
DELISTED
Endo International plc
ENDP
| $50.3M | 4.51% |
+560,443
| New | +$46.9M |
|
|
ASPX
7
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $41.9M | 3.76% |
+417,533
| New | +$27.8M |
|
|
8
Biogen
BIIB
$29.1B
| $41.3M | 3.7% |
97,713
+54,600
| +127% | +$21.5M |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $37.2M | 3.34% |
1,052,666
+68,700
| +7% | +$2.34M |
|
|
ALR
10
DELISTED
Alere Inc
ALR
| $32.5M | 2.92% |
+664,138
| New | +$29.1M |
|
|
CMRX
11
DELISTED
Chimerix, Inc.
CMRX
| $31.8M | 2.86% |
844,456
-312,728
| -27% | -$12.4M |
|
12
Insmed
INSM
$23.8B
| $28.7M | 2.58% |
1,381,828
+369,457
| +36% | +$6.51M |
|
|
RCPT
13
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $26.3M | 2.36% |
159,413
-153,323
| -49% | -$19.4M |
|
14
Standard BioTools
LAB
$329M
| $23.7M | 2.13% |
562,437
-48,005
| -8% | -$1.9M |
|
|
AET
15
DELISTED
Aetna Inc
AET
| $22.6M | 2.03% |
+211,974
| New | +$20.8M |
|
16
DaVita
DVA
$14.9B
| $21.6M | 1.94% |
+265,858
| New | +$20.4M |
|
|
TVTY
17
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $21.2M | 1.9% |
1,074,033
+5,544
| +0.5% | +$116K |
|
18
Ultragenyx Pharmaceutical
RARE
$3.12B
| $20.7M | 1.85% |
+332,600
| New | +$18.5M |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $19.9M | 1.79% |
1,415,482
+344,487
| +32% | +$4.69M |
|
|
CIVI
20
DELISTED
Civitas Solutions, Inc.
CIVI
| $18.4M | 1.65% |
879,485
| – | – |
|
|
CSLT
21
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $18.1M | 1.63% |
2,336,498
+1,089,230
| +87% | +$9.32M |
|
|
MODN
22
DELISTED
MODEL N, INC.
MODN
| $17.5M | 1.57% |
1,461,678
| – | – |
|
23
Jazz Pharmaceuticals
JAZZ
$15B
| $17.3M | 1.55% |
+100,000
| New | +$17.2M |
|
|
ZSPH
24
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $17.1M | 1.53% |
405,688
-119,014
| -23% | -$5.44M |
|
|
ADVM
25
DELISTED
Adverum Biotechnologies
ADVM
| $17.1M | 1.53% |
42,113
-27,794
| -40% | -$11.7M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO